Thermoneutral Housing and a Western Diet Combination Exacerbates Dysferlin‐Deficient Muscular Dystrophy von Donen, Graham S., White, Zoe, Sauge, Elodie, Ritso, Morten, Theret, Marine, Boyd, John, Devlin, Angela M., Rossi, Fabio M. V., Bernatchez, Pascal

Volltext

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy ty... von White, Zoe, Milad, Nadia, Tehrani, Arash Y, Chen, William Wei-Han, Donen, Graham, Sellers, Stephanie L, Bernatchez, Pascal

Volltext

Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice von White, Zoe, Sun, Zeren, Sauge, Elodie, Cox, Dan, Donen, Graham, Pechkovsky, Dmitri, Straub, Volker, Francis, Gordon A, Bernatchez, Pascal

Volltext

Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective von Donen, Graham, Milad, Nadia, Bernatchez, Pascal

Volltext

Heterogenous improvements in endothelial function by sub-blood pressure lowering doses of ARBs result in major anti-aortic root remodeling effects von Tehrani, Arash Y., Zhao, Roy, Donen, Graham, Bernatchez, Pascal

Volltext

Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties von Sauge, Elodie, Pechkovsky, Dmitri, Atmuri, N.D. Prasad, Tehrani, Arash Y., White, Zoe, Dong, Ying, Cait, Jessica, Hughes, Michael, Tam, Anthony, Donen, Graham, Yuen, Christopher, Walker, Michael J.A., McNagny, Kelly M., Sin, Don D., Ciufolini, Marco A., Bernatchez, Pascal

Volltext